Clinical Trial

Theranostic Applications of Radionuclides in Prostate Cancer

Name: Theranostic Applications of Radionuclides in Prostate Cancer — clinical trial record (NCT07559201)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The objective of the study is to construct a noninvasive approach ACP3 targeted PET/CT to detect tumor lesions in patients with prostate cancer and to compare with PSMA/FDG PET/CT.

Trial Details

NCT Number	NCT07559201
Lead Sponsor	Guilin Medical University, China
Conditions	Prostate Cancer (Diagnosis)
Enrollment	100 participants
Start Date	2026-01-01
Primary Completion	2029-12-31 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-30